liver cancer
Conditions
Interventions
Case series:CalliSpheres drug-eluting microspheres for transcatheter arterial embolization
Sponsors
Sichuan Provincial People's Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) aged 18-70 years, gender not limited; 2) HCC diagnosed by pathology or AASLD standard; 3) excess Milan standard (Milan standard: if the tumor diameter is less than or equal to 5cm, or if there are 2 ~ 3 tumor bodies at the same time and the maximum diameter of the tumor body is less than or equal to 3cm, without invasion of large blood vessels and intrahepatic and extrahepatic metastasis), the patients who are expected to receive liver transplantation are required to receive liver transplantation. 4) understand and sign the informed consent.
Exclusion criteria
Exclusion criteria: 1) invasion of large blood vessels; 2) the presence of extrahepatic metastasis; 3) receive other therapeutic methods (such as RFA); 4) decompensation of liver function (bilirubin >3mg/dl, AST/ALT>5 times the upper limit or >250U/l); 5) ECOG score >2 points. 6) contraindications to angiography.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| rate of downstaging;relapse free survival; | — |
Secondary
| Measure | Time frame |
|---|---|
| ????????;Microsphere distribution region;Tumor response rate imaging (mRECIST) was compared with tumor pathological response rate; | — |
Countries
China
Contacts
Public ContactXie Ping
Outcome results
None listed